Hemu Gene

About:

Hemu Gene is a gene therapy technology developer. It has two gene editing platforms: lentivirus, CRISPR and Cas.

Website: http://hemogen.cn

Top Investors: BGI Co-Win

Description:

Hemu Gene develops gene therapy technology to treat hemoglobin disease. With independent research and development capabilities, a reliable quality management system, and two main gene editing platforms—lentivirus and CRISPR/Cas—Hemu Gene continues to focus on the study, creation, and use of gene therapy vectors and genetic engineering technology. The company has set up additional hematopoietic stem gene therapy production lines and is actively engaged in international clinical collaboration and international registration declaration.